Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Filiberto Cedeno-Laurent"'
Publikováno v:
Microbiology Research, Vol 2, Iss 1, Pp e11-e11 (2011)
Opportunistic infections and invasive primary tumors represent major causes of morbidity and mortality in HIV-1-infected individuals. HIV-1 involvement of the central nervous system (CNS) affects nearly half of seropositive patients, being the primar
Externí odkaz:
https://doaj.org/article/4719a5bc60444db9bfa1e8bb99bd072c
Autor:
Amrom E. Obstfeld, Roberto A. Novoa, Carmela C. Vittorio, Filiberto Cedeno-Laurent, Ellen J. Kim, Wen-Kai Weng, Alain H. Rook, Maria Wysocka
Publikováno v:
Journal of Cutaneous Pathology. 44:462-466
Loss of CD26 surface expression on the circulating malignant T-cell is the most widely accepted diagnostic marker in patients with leukemic cutaneous T-cell lymphoma (CTCL). CTCL cases with reemergence of CD7 and/or CD26 surface expression are unusua
Publikováno v:
Glycoconjugate Journal. 29:619-625
Cytotoxic CD8(+) T cells are major players of anti-tumor immune responses, as their functional activity can limit tumor growth and progression. Data show that cytotoxic T cells efficiently control the proliferation of tumor cells through major histoc
Autor:
Rachael A. Clark, Charles J. Dimitroff, Filiberto Cedeno-Laurent, Thomas S. Kupper, Rei Watanabe, Jessica E. Teague
Publikováno v:
Blood. 119:3534-3538
Tumor-derived galectin-1 (Gal-1), a β-galactoside–binding S-type lectin, has been shown to encourage T-cell death and promote T cell–mediated tumor immune escape. In this report, we show that patients with leukemic cutaneous T-cell lymphomas, kn
Autor:
Steven R. Barthel, Filiberto Cedeno-Laurent, Vijay K. Kuchroo, Charles J. Dimitroff, Matthew J. Opperman
Publikováno v:
The Journal of Immunology
Galectin-1 (Gal-1), a β-galactoside–binding protein, can alter fate and effector function of Th cells; however, little is known about how Gal-1 induces Th cell differentiation. In this article, we show that both uncommitted and polarized Th cells
Autor:
Lana Schaffer, Gilberto E. Hernandez, Steven R. Barthel, Sriram Neelamegham, Filiberto Cedeno-Laurent, Charles J. Dimitroff, Stuart M. Haslam, Simon J. North, Khushi L. Matta, Anne Dell, Aristotelis Antonopoulos, Shilpa A. Patil
Publikováno v:
The Journal of Biological Chemistry
Prior studies have shown that treatment with the peracetylated 4-fluorinated analog of glucosamine (4-F-GlcNAc) elicits anti-skin inflammatory activity by ablating N-acetyllactosamine (LacNAc), sialyl Lewis X (sLe(X)), and related lectin ligands on e
Publikováno v:
Lupus. 25(3)
Cutaneous manifestations are often the presenting sign of internal malignancies. Up to 50% of patients with acute myeloblastic leukemia (AML) have skin findings. Connective tissue disease, particularly dermatomyositis and, rarely, lupus, have been re
Autor:
Bernice M. Benoit, Filiberto Cedeno-Laurent, Ellen J. Kim, Carmela C. Vittorio, Elisha M. Singer, Alain H. Rook, Gil Yosipovitch, Maria Wysocka
Publikováno v:
Clinical immunology (Orlando, Fla.). 158(1)
Pruritus is one of the cardinal symptoms found in patients with leukemic cutaneous T cell lymphoma (CTCL). The nature of the pruritus experienced by CTCL patients is complex, involving different pathways and cell mediators, thus making it poorly resp
Autor:
George F. Murphy, Jennifer Liang, Charles J. Dimitroff, Hans R. Widlund, Erika M. Yazawa, Abrar A. Qureshi, Alvaro C. Laga, Matthew J. Opperman, Steven R. Barthel, Jennifer Y. Lin, Martin C. Mihm, Jenna E. Geddes-Sweeney, Tobias Schatton, Filiberto Cedeno-Laurent, Kempland C. Walley
Publikováno v:
The Journal of investigative dermatology. 135(7)
Galectin-1 (Gal-1)-binding to Gal-1 ligands on immune and endothelial cells can influence melanoma development through dampening antitumor immune responses and promoting angiogenesis. However, whether Gal-1 ligands are functionally expressed on melan